Skip to content

Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation

Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01210781
Enrollment
500
Registered
2010-09-28
Start date
2009-09-30
Completion date
2025-12-31
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Movement Disorders

Keywords

All indication for deep brain stimulation (DBS)

Brief summary

Deep brain stimulation (DBS) has been established as therapy for severe forms of Parkinson's disease and other indications. A common target for stimulation is the subthalamic nucleus (STN). Nevertheless, there is no agreement on the mechanisms how DBS leads to clinical improvement. The project aims to describe the variability of target coordinates in the patient group and to relate it to clinical outcome as documented in standardized questionaires. * Trial with surgical intervention

Detailed description

Deep brain stimulation (DBS) has been established as therapy for severe forms of Parkinson's disease and other indications. A common target for stimulation is the subthalamic nucleus (STN). Nevertheless, there is no agreement on the mechanisms how DBS leads to clinical improvement. The project aims to describe the variability of target coordinates in the patient group and to relate it to clinical outcome as documented in standardized questionaires.

Interventions

deep brain stimulation (DBS) is in itself not part of this study but a clinical indication. The study aims at documenting DBS parameters and outcome

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients fullfill all criteria for implantation of deep brain stimulation (DBS) electrodes * Patients are able to give informed written consent

Exclusion criteria

* Patients do not their give informed written consent

Design outcomes

Primary

MeasureTime frameDescription
neurological outcome5 yearsUPDRS

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026